• 随着电子商务的快速发展,物流行业的创新和发展变得尤为重要。
  • 隐私保护和数据安全成为数字时代的重要议题。
  • 数字化转型加速了企业对云计算和大数据技术的依赖。
  • 随着全球健康危机的持续,公共卫生体系的完善成为紧迫议题。
  • 网络安全问题日益严重,个人数据保护成为公众关注的焦点。
  • 随着移动支付的普及,现金交易正在逐渐减少。
  • 智能家居设备使日常生活更加便捷,推动了居住环境的智能化。
  • 随着全球经济不确定性增加,跨国公司的社会责任和环境影响受到更多审视。
  • 心理健康问题在现代社会中越来越受到重视。
  • 隐私保护在数字化时代变得更加重要,数据泄露事件频发。
  • 远程工作模式的普及引发了对工作生活平衡和城市居住模式的新思考。
  • 社交媒体的普及正在重塑政治沟通和公众参与。
  • 数字货币的普及正在改变传统的金融交易方式。
  • 气候变化导致的极端天气事件频发,促使国际社会加强应对气候变化的合作。
  • 人工智能在医疗领域的应用为疾病诊断和治疗提供了新的解决方案。
  • 加密货币市场的波动性引起了投资者和监管机构的密切关注。
  • 太空探索的商业化为航天产业带来了新的投资和创新。
  • 随着太空探索的商业化,航天产业迎来了新的发展机遇。
  • 在线教育平台的兴起挑战了传统教育模式和学习习惯。
  • 隐私保护和数据安全成为数字时代的重要议题。
  • 随着环保意识的提高,可持续消费和绿色生活方式成为新的消费趋势。
  • 随着移动支付的普及,现金交易正在逐渐减少。
  • 电动汽车的兴起预示着交通行业的未来趋势。
  • 在线教育平台的兴起为传统教育模式带来了挑战和机遇。
  • 太空探索技术的进步为人类带来了新的可能。
  • Pioglitazone up-regulates MALAT1 and promotes the proliferation of endothelial progenitor cells through increasing c-Myc expression in type 2 diabetes mellitus | Hu | Aging Pathobiology and Therapeutics

    Pioglitazone up-regulates MALAT1 and promotes the proliferation of endothelial progenitor cells through increasing c-Myc expression in type 2 diabetes mellitus

    Chen Hu, Yan Sun, Xiaoxu Yang

    Abstract


    Objective: Evidence suggests that pioglitazone improves the function of endothelial progenitor cells (EPCs). However, the knowledge of its molecular mechanism remains limited. In the present study, the role of long non-coding RNA MATAL1 in modulating the number and function of EPCS in type 2 diabetes mellitus (T2DM) was characterized.

    Methods: Circulating EPCs were obtained from peripheral blood of healthy subjects and T2DM patients with or without pioglitazone treatment. The in vitro experiments were conducted in bone marrow-EPCs to evaluate the effect of pioglitazone and its possible mechanism. 

    Results: Pioglitazone increased circulating EPCs number and improved their function in T2DM patients. Transfected EPCs with siRNA-MALAT1, the increase of c-Myc protein expression induced by pioglitazone treatment was canceled. In db/db diabetic mice, a glucose tolerance test showed that pioglitazone increased glucose tolerance, which was reversed by siRNA-MALAT1.

    Conclusion: Pioglitazone improves the EPCs function possibly through regulating MALAT1 and c-Myc expression in T2DM.

    Keywords: pioglitazone; diabetes mellitus; MALAT1; endothelial function; glucose tolerant




    Subscribe to receive issue release notifications
    and newsletters from journals